Effective suppression of donor specific antibody production by Cathepsin S inhibitors in a mouse transplantation model-Reference-Cited by-同舟云学术

Effective suppression of donor specific antibody production by Cathepsin S inhibitors in a mouse transplantation model

Published:2018-11 Issue: Volume:838 Page:145-152
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Kubo Kaori,Kawato Yuka,Nakamura Koji,Nakajima Yutaka,Nakagawa Terry Y.,Hanaoka Kaori,Oshima Shinsuke,Fukahori Hidehiko,Inami Masamichi,Morokata Tatsuaki,Higashi Yasuyuki

Publisher

Elsevier BV

Subject

Pharmacology

Reference43 articles.

1. Heterologous immunity provides a potent barrier to transplantation tolerance;Adams;J. Clin. Investig.,2003

2. Role of memory T cells in allograft rejection and tolerance;Benichou;Front. Immunol.,2017

3. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses;Bishop;Transplantation,1994

4. Preferential priming of alloreactive T cells with indirect reactivity;Brennan;Am. J. Transplant.,2009

5. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries;Collins;J. Am. Soc. Nephrol.,1999

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cathepsin-S/protease-activated receptor-(PAR)-2 axis drives chronic allograft vasculopathy and is a molecular target for therapeutic intervention;Transplant Immunology;2023-04

2. Binding mechanism of selective cathepsin K/S inhibition revealed from molecular simulations;Structural Chemistry;2023-02-07

3. Cathepsin S (CTSS) activity in health and disease - A treasure trove of untapped clinical potential;Molecular Aspects of Medicine;2022-12

4. Potential benefit of the cathepsin S inhibitor, ASP1617, as a treatment for systemic lupus erythematosus;European Journal of Pharmacology;2022-03

5. Inhibition of cathepsin S attenuates myocardial ischemia/reperfusion injury by suppressing inflammation and apoptosis;Journal of Cellular Physiology;2020-07-13